메뉴 건너뛰기




Volumn 164, Issue 5, 2014, Pages

Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis

Author keywords

BMI; Body mass index; CF; CF Registry; CFF; CFF Patient Registry; Cystic Fibrosis; Cystic Fibrosis Foundation; FEV1 ; Forced expiratory volume in 1 second percent; Pancreatic enzyme replacement therapy; PERT

Indexed keywords

GROWTH HORMONE; PANCREAS ENZYME;

EID: 84899106021     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.01.022     Document Type: Article
Times cited : (38)

References (28)
  • 2
    • 0033827478 scopus 로고    scopus 로고
    • Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: Analysis of the Cystic Fibrosis Foundation National CF Patient Registry
    • B.S. Zemel, A.F. Jawad, S. Fitzsimmons, and V. Stallings Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry J Pediatr 137 2000 374 380
    • (2000) J Pediatr , vol.137 , pp. 374-380
    • Zemel, B.S.1    Jawad, A.F.2    Fitzsimmons, S.3    Stallings, V.4
  • 3
    • 0027183417 scopus 로고
    • Nutritional management of cystic fibrosis
    • P.B. Pencharz, and P.R. Durie Nutritional management of cystic fibrosis Ann Rev Nutr 13 1993 111 136
    • (1993) Ann Rev Nutr , vol.13 , pp. 111-136
    • Pencharz, P.B.1    Durie, P.R.2
  • 5
  • 6
    • 0023923679 scopus 로고
    • A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto
    • M. Corey, F.J. McLaughlin, M. Williams, and H. Levison A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto J Clin Epidemiol 41 1988 588 591
    • (1988) J Clin Epidemiol , vol.41 , pp. 588-591
    • Corey, M.1    McLaughlin, F.J.2    Williams, M.3    Levison, H.4
  • 7
    • 0017843165 scopus 로고
    • Relative underweight in cystic fibrosis and its prognostic value
    • R. Kraemer, A. Rudeberg, B. Hadorn, and E. Rossi Relative underweight in cystic fibrosis and its prognostic value Acta Paediatr Scand 67 1978 33 37
    • (1978) Acta Paediatr Scand , vol.67 , pp. 33-37
    • Kraemer, R.1    Rudeberg, A.2    Hadorn, B.3    Rossi, E.4
  • 8
    • 42649103313 scopus 로고    scopus 로고
    • Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review
    • V.A. Stallings, L.J. Stark, K.A. Robinson, A.P. Feranchak, and H. Quinton Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review J Am Diet Assoc 108 2008 832 839
    • (2008) J Am Diet Assoc , vol.108 , pp. 832-839
    • Stallings, V.A.1    Stark, L.J.2    Robinson, K.A.3    Feranchak, A.P.4    Quinton, H.5
  • 9
    • 0028827338 scopus 로고
    • Fibrosing colonopathy in cystic fibrosis: Results of a case-control study
    • R. Smyth, D. Ashby, U. O'Hea, E. Burros, P. Lewis, and D. van Velzen et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study Lancet 346 1995 1247 1251
    • (1995) Lancet , vol.346 , pp. 1247-1251
    • Smyth, R.1    Ashby, D.2    O'Hea, U.3    Burros, E.4    Lewis, P.5    Van Velzen, D.6
  • 10
    • 0030905117 scopus 로고    scopus 로고
    • High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis
    • S. FitzSimmons, G. Burkhart, D. Borowitz, R.J. Grand, T. Hammerstrom, and P. Drurie et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis N Engl J Med 336 1997 1283 1289
    • (1997) N Engl J Med , vol.336 , pp. 1283-1289
    • Fitzsimmons, S.1    Burkhart, G.2    Borowitz, D.3    Grand, R.J.4    Hammerstrom, T.5    Drurie, P.6
  • 11
    • 0037209069 scopus 로고    scopus 로고
    • Mortality of cystic fibrosis patients being treated with tobramycin solution for inhalation
    • K.J. Rothman, and C.E. Wenthworth III Mortality of cystic fibrosis patients being treated with tobramycin solution for inhalation Epidemiology 14 2003 55 59
    • (2003) Epidemiology , vol.14 , pp. 55-59
    • Rothman, K.J.1    Wenthworth III, C.E.2
  • 12
    • 0037252230 scopus 로고    scopus 로고
    • Factors influencing outcomes in cystic fibrosis: A center based analysis
    • C. Johnson, S.M. Butler, M.W. Konstan, W. Morgan, and M.E. Wohl Factors influencing outcomes in cystic fibrosis: a center based analysis Chest 123 2003 20 27
    • (2003) Chest , vol.123 , pp. 20-27
    • Johnson, C.1    Butler, S.M.2    Konstan, M.W.3    Morgan, W.4    Wohl, M.E.5
  • 13
    • 33947155711 scopus 로고    scopus 로고
    • Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function
    • R. Padman, S.A. McColley, D.P. Miller, M.W. Konstan, W.J. Morgan, and M.S. Schechter et al. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function Pediatrics 119 2007 e531 e537
    • (2007) Pediatrics , vol.119
    • Padman, R.1    McColley, S.A.2    Miller, D.P.3    Konstan, M.W.4    Morgan, W.J.5    Schechter, M.S.6
  • 14
    • 0028098221 scopus 로고
    • High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis
    • P.J. Oades, A. Bush, P.S. Ong, and R.J. Brereton High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis Lancet 343 1994 109
    • (1994) Lancet , vol.343 , pp. 109
    • Oades, P.J.1    Bush, A.2    Ong, P.S.3    Brereton, R.J.4
  • 15
    • 0028098221 scopus 로고
    • High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis
    • C.A. Campbell, J. Forrest, and C. Musgrove High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis Lancet 343 1994 109 110
    • (1994) Lancet , vol.343 , pp. 109-110
    • Campbell, C.A.1    Forrest, J.2    Musgrove, C.3
  • 16
    • 0028885145 scopus 로고
    • Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy: Consensus committee
    • D. Borowitz, R. Grand, and P. Durie Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy: consensus committee J Pediatr 127 1995 681 684
    • (1995) J Pediatr , vol.127 , pp. 681-684
    • Borowitz, D.1    Grand, R.2    Durie, P.3
  • 17
    • 0036735017 scopus 로고    scopus 로고
    • Consensus report on nutrition for pediatric patients with cystic fibrosis
    • D. Borowitz, R. Baker, and V. Stallings Consensus report on nutrition for pediatric patients with cystic fibrosis J Pediatr Gastroenterol Nutr 35 2002 246 259
    • (2002) J Pediatr Gastroenterol Nutr , vol.35 , pp. 246-259
    • Borowitz, D.1    Baker, R.2    Stallings, V.3
  • 18
    • 13444252444 scopus 로고    scopus 로고
    • Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis
    • S. Baker, D. Borowitz, L. Duffy, L. Fitzpatrick, J. Gyamfi, and R. Baker Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis J Pediatr 146 2005 189 193
    • (2005) J Pediatr , vol.146 , pp. 189-193
    • Baker, S.1    Borowitz, D.2    Duffy, L.3    Fitzpatrick, L.4    Gyamfi, J.5    Baker, R.6
  • 19
    • 80051576200 scopus 로고    scopus 로고
    • Location and duration of treatment of cystic fibrosis respiratory exacerbations
    • author reply 279
    • M.S. Schechter, J. Wagener, M.W. Konstan, and W. Morgan Location and duration of treatment of cystic fibrosis respiratory exacerbations Am J Respir Crit Care Med 184 2011 278 author reply 279
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 278
    • Schechter, M.S.1    Wagener, J.2    Konstan, M.W.3    Morgan, W.4
  • 20
    • 56249132492 scopus 로고    scopus 로고
    • Patient registry analyses: Seize the data, but caveat lector
    • M.S. Schechter Patient registry analyses: seize the data, but caveat lector J Pediatr 153 2008 733 735
    • (2008) J Pediatr , vol.153 , pp. 733-735
    • Schechter, M.S.1
  • 21
    • 0344628714 scopus 로고    scopus 로고
    • Uses of ecologic studies in the assessment of intended treatment effects
    • S. Wen, and M. Kramer Uses of ecologic studies in the assessment of intended treatment effects J Clin Epidemiol 52 1999 7 12
    • (1999) J Clin Epidemiol , vol.52 , pp. 7-12
    • Wen, S.1    Kramer, M.2
  • 22
    • 70649113093 scopus 로고    scopus 로고
    • A most stubborn bias: No adjustment method fully resolves confounding by indication in observational studies
    • J. Bosco, R. Silliman, S. Thwin, A. Geiger, D. Buist, and M. Prout et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies J Clin Epidemiol 63 2010 64 74
    • (2010) J Clin Epidemiol , vol.63 , pp. 64-74
    • Bosco, J.1    Silliman, R.2    Thwin, S.3    Geiger, A.4    Buist, D.5    Prout, M.6
  • 23
    • 84880876390 scopus 로고    scopus 로고
    • Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis. An instrumental variables analysis
    • R.D. Vandyke, G.L. McPhail, B. Huang, M.C. Fenchel, R.S. Amin, and A.C. Carle et al. Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis. An instrumental variables analysis Ann Am Thorac Soc 10 2013 205 212
    • (2013) Ann Am Thorac Soc , vol.10 , pp. 205-212
    • Vandyke, R.D.1    McPhail, G.L.2    Huang, B.3    Fenchel, M.C.4    Amin, R.S.5    Carle, A.C.6
  • 24
    • 0038663174 scopus 로고    scopus 로고
    • Effect of genotype on phenotype and mortality in cystic fibrosis patients: A retrospective cohort study
    • E.F. McKone, S.S. Emerson, K.L. Edwards, and M.L. Aitken Effect of genotype on phenotype and mortality in cystic fibrosis patients: a retrospective cohort study Lancet 363 2003 1671 1676
    • (2003) Lancet , vol.363 , pp. 1671-1676
    • McKone, E.F.1    Emerson, S.S.2    Edwards, K.L.3    Aitken, M.L.4
  • 27
    • 17744372496 scopus 로고    scopus 로고
    • Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group
    • P. Farrell, M. Kosorok, M. Rock, A. Laxova, L. Zeng, and H. Lai et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group Pediatrics 107 2001 1 13
    • (2001) Pediatrics , vol.107 , pp. 1-13
    • Farrell, P.1    Kosorok, M.2    Rock, M.3    Laxova, A.4    Zeng, L.5    Lai, H.6
  • 28
    • 84874660385 scopus 로고    scopus 로고
    • Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis
    • E. Yen, H. Quinton, and D. Borowitz Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis J Pediatr 162 2013 530 535
    • (2013) J Pediatr , vol.162 , pp. 530-535
    • Yen, E.1    Quinton, H.2    Borowitz, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.